Gene · 6430
SRSF5: serine and arginine rich splicing factor 5
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. SRSF5: serine and arginine rich splicing factor 5. Genes, record 6430. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/6430
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q13243 | Serine/arginine-rich splicing factor 5 | 272 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents34
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 63098 | Q13243 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 63100 | Q13243 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 63101 | Q13243 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 11134 | Q13243 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 11590 | Q13243 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 5902 | Q13243 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 11590 | Q13243 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 11134 | Q13243 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 5902 | Q13243 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 77774 | Q13243 | Espacenet |
1 to 10 of 34
See all 34 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,247
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | SRSF5 papers | Newest fiscal year |
|---|---|---|---|
| R01GM042699 | Biochemistry of Pre-mRNA Splicing | 8 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 6 | 2025 |
| P30CA045508 | CSHL Cancer Center Support Grant | 6 | 2025 |
| ZIAHD001607 | Protein Trafficking In The Endosomal-Lysosomal System | 5 | 2025 |
| P01CA013106 | Targeting Transcription and Splicing in Cancer | 4 | 2025 |
| R01HL128239 | Genetic and molecular basis for SRSF2 mutations in myelodysplasia | 4 | 2025 |
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 3 | 2025 |
| P30CA014051 | Cancer Center Support (Core) Grant | 3 | 2025 |
| P30CA014520 | UW Comprehensive Cancer Center Support | 3 | 2025 |
| P30CA034196 | Cancer Center Support (CORE) Grant | 3 | 2025 |
1 to 10 of 1,247Source NIH's project files
See all 1,247 nih grantsPapers1,509
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptome-based identification and experimental validation of a key gene in Alzheimer's disease using dermal fibroblasts. | J Alzheimers Dis | 2026 | 42024084 | PubTator, text mining | PubMed |
| The biased adenosine-rich content of the HIV-1 genome serves as a molecular signature that facilitates efficient packaging. | Proc Natl Acad Sci U S A | 2026 | 41926539 | PubTator, text mining | PubMed |
| [Expression, Prognostic and Functional Analysis of SRSF Family Proteins in Non-small Cell Lung Cancer]. | Zhongguo Fei Ai Za Zhi | 2026 | 41916911 | PubTator, text mining | PubMed |
| CHAtRF Modulates Cardiac Hypertrophy via SRSF5-Dependent Regulation of Psmg4 Alternative Splicing. | Research (Wash D C) | 2026 | 41907183 | PubTator, text mining | PubMed |
| Pathogenic Analysis of Two SLC22A5 Variants That Alter RNA Splicing in Patients with Primary Carnitine Deficiency. | Int J Neonatal Screen | 2026 | 41892025 | PubTator, text mining | PubMed |
| Unveiling biomarkers of telitacicept's efficacy in SLE treatment through proteomics and metabolomics. | Front Immunol | 2026 | 41859090 | PubTator, text mining | PubMed |
| Exosomal circ0000549 promotes MNNG‑induced gastric cancer through miR‑15b‑5p/KIF1B. | Int J Mol Med | 2026 | 41789656 | PubTator, text mining | PubMed |
| Genetic correlation-guided mega-analysis of DO mice provides mechanistic insight and candidate genes for age-related pathologies. | PLoS Genet | 2026 | 41758904 | PubTator, text mining | PubMed |
| Acid sphingomyelinase inhibition restores RPE homeostasis and photoreceptor function in preclinical Stargardt macular degeneration models. | bioRxiv | 2026 | 41757049 | PubTator, text mining | PubMed |
| SMURF1 Downregulation Highlights Its Potential Role in Breast Cancer. | Int J Mol Sci | 2026 | 41752056 | PubTator, text mining | PubMed |
1 to 10 of 1,509
See all 1,509 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/6430
GET https://conductscience.org/api/genes/v1/6430/patents?page=2